PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

Medical Affairs

News Category

Posts navigation

1 2 Next
Takeaways from our April joint webinar- Medical Affairs 3.0: A Discipline Comes of Age

Takeaways from our April joint webinar- Medical Affairs 3.0: A Discipline Comes of Age

We enjoyed our first joint webinar with PharmaMedic and Triducive of 2022. Our guest speakers, Dr Malcolm Barratt-Johnson (PharmaMedic) and Tim Warren (Triducive) joined Nick Williams (Triducive) for a discussion and interactive Q&A on the evolving and increasingly strategic role of medical affairs within pharma and life sciences businesses. Read on for the key takeaways.

3 May 2022
Read More
Living with COVID- the role of antivirals

Living with COVID- the role of antivirals

In the UK, we now seem to be moving into a new phase of pandemic management, with the government aiming to” transition to managing COVID-19 like other respiratory illnesses”. In their recent March 2022 statement, the government attributes this evolution in approach to vaccines and treatments. In this short article, we overview the current role of antivirals and monoclonal antibodies and look ahead to future developments in our attempt to manage the day-to day risks of living with COVID-19.

5 Apr 2022
Read More
Join Our Free Webinar: Medical Affairs 3.0: A Discipline Comes of Age – Focus on evidence generation & dissemination for strategic impact

Join Our Free Webinar: Medical Affairs 3.0: A Discipline Comes of Age – Focus on evidence generation & dissemination for strategic impact

Join Triducive and PharmaMedic for an interactive webinar on Thursday 28th April at 8.00AM. Keynote speakers Dr Malcolm Barratt-Johnson and Tim Warren will be discussing the strategic role of medical affairs in Pharma and the potential role of Delphi based studies for strategic impact. Find out more.

29 Mar 2022
Read More
The value of a pharmaceutical physician as a Non-Executive Director

The value of a pharmaceutical physician as a Non-Executive Director

Non-Executive Directors play an integral role for any organisation, not least within the life science space where leadership often needs to draw on a broad range of strategic and tactical expertise to drive the business forward. In this short Q&A article, we interview PharmaMedic Managing Director Dr Malcolm Barratt-Johnson about the value that a pharmaceutical physician delivers in the role of NED.

22 Mar 2022
Read More
Join our Virtual Breakfast Briefing:  Medical Affairs in 2022:  Business as usual, or a reshaped environment?

Join our Virtual Breakfast Briefing: Medical Affairs in 2022: Business as usual, or a reshaped environment?

PharmaMedic is delighted to announce our next virtual breakfast briefing on Thursday 24th February 2022 at 8 am. For this virtual session, we invite you to join experts Dr Malcolm Barratt-Johnson, Mr Guy Francis, Dr Lucy Cook and Mr Andrew Wise for a lively panel discussion tackling the key industry and medical affairs trends we expect to emerge in 2022 and how we can best adapt to succeed. Learn more about the agenda and register here.

2 Feb 2022
Read More
The Role of Public/ Private Collaborations in Innovation- Highlights from our Virtual Breakfast Briefing

The Role of Public/ Private Collaborations in Innovation- Highlights from our Virtual Breakfast Briefing

Against a backdrop of achievements yielded from public/private collaborations in the context of the pandemic response, we focused our latest virtual briefing on the crucial role such partnerships play in furthering biopharma and medical devices innovation. We share highlights from the event and provide the catch-up recording in this brief summary.

21 Jul 2021
Read More
PMC shares ILAP thought leadership in LBIC’s summer newsletter

PMC shares ILAP thought leadership in LBIC’s summer newsletter

PMC was delighted to feature in the latest LBIC newsletter from the London BioScience Innovation Centre discussing how the ILAP scheme is helping to secure the UK’s position as a life science superpower. Learn more.

14 Jul 2021
Read More
What does the future for clinical research delivery hold in the UK?

What does the future for clinical research delivery hold in the UK?

In March 2021, the government published its document Saving and Improving lives: The Future of Clinical Research Delivery. The paper laid out an ambitious vision for a more patient-centred, pro-innovation and data-enabled clinical research environment in the UK. Following the publication of the implementation plan in June, we summarise the key themes in this article.

7 Jul 2021
Read More
PMC announces next virtual breakfast briefing discussing the role of public/ private collaborations

PMC announces next virtual breakfast briefing discussing the role of public/ private collaborations

Join PMC for our next virtual breakfast briefing on Wednesday 21st July 2021 at 8am. Our topic for this session is “The role of public/ private collaborations to further biopharma and medical devices innovation”. We are delighted to welcome Nicki Bromwich, Chief Operating Officer of MedCity who will join Dr Malcolm Barratt-Johnson, Managing Director of PMC to discuss the ecosystem of public/ private collaboration and how it supports innovation. Read more and register.

1 Jul 2021
Read More
Patients and pharma stand to benefit from Innovative Licensing and Access Pathway scheme

Patients and pharma stand to benefit from Innovative Licensing and Access Pathway scheme

The MHRA's recently launched Innovative Licensing and Access Pathway scheme (ILAP) forms part of a bold vision for the UK to incentivise and support life sciences development as we emerge into a post-Brexit regulatory and clinical trials environment. PharmaMedic Consultancy is currently supporting several clients with their applications, and in this article, we share more insights about the scheme and how it stands to benefit patients and sponsors.

25 May 2021
Read More

Posts navigation

1 2 Next

Medical AffairsCategories

  • No categories

Medical AffairsTags

#projectorbis #regulatory AI Biotech Capabilities Brochure COVID-19 DITTurkey Drug Price Healthcare Medical Affairs medicaldevices Patient Care Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2022 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital